Buy ATE stock for a double, Echelon says : vimarsana.com

Following the company’s Q2, 2024 interim results, Echelon analyst Stefan Quenneville still thinks there is money to be made on Antibe Therapeutics

Related Keywords

Dan Legault , Stefan Quenneville , , Echelon Capital Markets , Antibe Therapeutics , Antibe Therapeutics Stock Quote , Speculative Buy ,